ReviewHuman

Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance

Sports medicine (Auckland, N.Z.), 2026 Aug. Mendias CL, Awan TM.

Study type
Review
Subjects
Human participants (PubMed MeSH: Humans)
Journal
Sports medicine (Auckland, N.Z.)
Published
2026 Aug
PubMed
PMID 41966639 ↗
DOI
10.1007/s40279-026-02437-0 ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

HGH Fragment 176-191 →is bpc 157 banned →

Indexed under

MeSH terms assigned by the National Library of Medicine.

HumansPeptidesAthletic InjuriesAthletic PerformanceMusculoskeletal SystemAnimalsPerformance-Enhancing SubstancesPeptide Fragments

Other papers on HGH Fragment 176-191

Journal article · 2001
The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds